臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yu c j"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 1636-1660 of 2308 (93 Page(s) Totally)
<< < 61 62 63 64 65 66 67 68 69 70 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-05-26T09:27:05Z	Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin	Chih-Hsin Yang;Yang P.-C;Ting-Fang Shih T;Tseng W.-Y.I;Hsu H.-H;Hu F.-C;Chen C.-M;Yu C.-J;Chang Y.-C; Chang Y.-C; Yu C.-J; Chen C.-M; Hu F.-C; Hsu H.-H; Tseng W.-Y.I; Ting-Fang Shih T; Yang P.-C; Chih-Hsin CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:03Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G;Yu C.-J;Tsai M.-F;Liao W.-Y;Chih-Hsin Yang;Jan I.-S;Yang P.-C;Shih J.-Y.; Wu S.-G; Yu C.-J; Tsai M.-F; Liao W.-Y; CHIH-HSIN YANG; Jan I.-S; Yang P.-C; Shih J.-Y.
臺大學術典藏	2020-05-26T09:27:02Z	Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer	Liao W.-Y;Chen J.-H;Wu M;Shih J.-Y;Chen K.-Y;Ho C.-C;Chih-Hsin Yang;Yu C.-J.; Liao W.-Y; Chen J.-H; Wu M; Shih J.-Y; Chen K.-Y; Ho C.-C; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:27:00Z	Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer	Lee J.-H; Lin Y.-L; Hsu W.-H; Chen H.-Y; Chang Y.-C; Yu C.-J; Shih J.-Y; Lin C.-C; Chen K.-Y; Ho C.-C; Laio W.-Y; Yang P.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:00Z	Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy	Tsai T.-H;Yang C.-Y;Ho C.-C;Liao W.-Y;Jan I.-S;Chen K.-Y;Wang J.-Y;Ruan S.-Y;Yu C.-J;Chih-Hsin Yang;Yang P.-C;Shih J.-Y.; Tsai T.-H; Yang C.-Y; Ho C.-C; Liao W.-Y; Jan I.-S; Chen K.-Y; Wang J.-Y; Ruan S.-Y; Yu C.-J; CHIH-HSIN YANG; Yang P.-C; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:59Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F;Hsieh M.-S;Wu S.-G;Chang Y.-L;Shih J.-Y;Liu Y.-N;Tsai M.-F;Tsai T.-H;Yu C.-J;Chih-Hsin Yang;Yang P.-C.; Chen Y.-F; Hsieh M.-S; Wu S.-G; Chang Y.-L; Shih J.-Y; Liu Y.-N; Tsai M.-F; Tsai T.-H; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:26:57Z	Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6	CHIH-HSIN YANG; Sequist L.V; Geater S.L; Tsai C.-M; Mok T.S.K; Schuler M; Yamamoto N; Yu C.-J; Ou S.H.I; Zhou C; Massey D; Zazulina V; Wu Y.-L.; Wu Y.-L.;Zazulina V;Massey D;Zhou C;Ou S.H.I;Yu C.-J;Yamamoto N;Schuler M;Mok T.S.K;Tsai C.-M;Geater S.L;Sequist L.V;Chih-Hsin Yang
臺大學術典藏	2020-05-26T09:26:57Z	Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer	Yang P.-C.; Shih J.-Y; Wu S.-G; Yu C.-J; CHIH-HSIN YANG; Wang Y.-F; Lin Y.-T; Lin Y.-T;Wang Y.-F;Chih-Hsin Yang;Yu C.-J;Wu S.-G;Shih J.-Y;Yang P.-C.
臺大學術典藏	2020-05-26T09:26:55Z	Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis	Yang P.-C.;Yu C.-J;Chih-Hsin Yang;Shih J.-Y;Chen K.-Y;Chen J.-H;Hsu C.-L; Hsu C.-L; Chen J.-H; Chen K.-Y; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:26:53Z	Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion	Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Hsieh M.-S;Wu S.-G;Tsai T.-H; Tsai T.-H; Wu S.-G; Hsieh M.-S; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:52Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis	Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Chang C.-H;Chen Y.-F;Lin C.-C;Lee J.-H;Liao B.-C; Liao B.-C; Lee J.-H; Lin C.-C; Chen Y.-F; Chang C.-H; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:50Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	Shih J.-Y.;Yang P.-C;Chih-Hsin Yang;Yu C.-J;Chang Y.-L;Wu S.-G;Hsieh M.-S;Chen Y.-F; Chen Y.-F; Hsieh M.-S; Wu S.-G; Chang Y.-L; Yu C.-J; CHIH-HSIN YANG; Yang P.-C; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:48Z	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients	Shih J.-Y.;Wen Y.-F;Chih-Hsin Yang;Yang P.-C;Yu C.-J;Chang Y.-L;Tsai M.-F;Liu Y.-N;Wu S-G; Wu S-G; Liu Y.-N; Tsai M.-F; Chang Y.-L; Yu C.-J; Yang P.-C; CHIH-HSIN YANG; Wen Y.-F; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:47Z	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Yang P.-C.;Rosell R;Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Yu K.-L;Liao W.-Y;Su K.-Y;Ruan S.-Y;Molina-Vila M.A;Chen L.-Y; Chen L.-Y; Molina-Vila M.A; Ruan S.-Y; Su K.-Y; Liao W.-Y; Yu K.-L; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG; Rosell R; Yang P.-C.
臺大學術典藏	2020-05-26T09:26:47Z	151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs	Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Ho C.-C;Lee Y.-F;Lin S.-Y;Lin C.-C;Bai Y.-Y;Liao B.-C; Liao B.-C; Bai Y.-Y; Lin C.-C; Lin S.-Y; Lee Y.-F; Ho C.-C; Shih J.-Y; Chang Y.-C; Yu C.-J; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:44Z	Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non?�Small-Cell Lung Cancer: Analysis and Literature Review	Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Lin Y.-T; Lin Y.-T; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:39Z	Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib	Shih J.-Y; Yu C.-J; Chih-Hsin CHIH-HSIN YANG; Lin C.-A; Liao W.-Y; Ho C.-C; Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Lin C.-A;Liao W.-Y;Ho C.-C
臺大學術典藏	2020-05-26T09:26:36Z	Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib	Yu C.-J.;Chih-Hsin Yang;Lin C.-C;Lin Z.-Z;Chen J.-S;Shih J.-Y;Chen K.-Y;Ho C.-C;Liao W.-Y;Yao Z.-H; Yao Z.-H; Liao W.-Y; Ho C.-C; Chen K.-Y; Shih J.-Y; Chen J.-S; Lin Z.-Z; Lin C.-C; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:34Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Yu C.-J.;Chih-Hsin Yang;Shih J.-Y;Lin C.-C;Lee J.-H;Chang Y.-L;Su K.-Y;Hsu W.-H;Hsu C.-L;Tsai T.-H;Chen K.-Y;Liao W.-Y;Ho C.-C;Liao B.-C;Yang C.-Y;Lin S.-Y; Lin S.-Y; Yang C.-Y; Liao B.-C; Ho C.-C; Liao W.-Y; Chen K.-Y; Tsai T.-H; Hsu C.-L; Hsu W.-H; Su K.-Y; Chang Y.-L; Lee J.-H; Lin C.-C; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:31Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Chih-Hsin Yang;Thress K.S;Huang D.D.-R;Bai Y.-Y;Chang Y.-L;Hsieh M.-S;Su K.-Y;Tsai T.-H;Lee J.-H;Liao W.-Y;Ho C.-C;Yu C.-J;Shih J.-Y;Lin C.-C; Lin C.-C; Shih J.-Y; Yu C.-J; Ho C.-C; Liao W.-Y; Lee J.-H; Tsai T.-H; Su K.-Y; Hsieh M.-S; Chang Y.-L; Bai Y.-Y; Huang D.D.-R; Thress K.S; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:29Z	Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors	Yang P.-C.;Chih-Hsin Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Ho C.-C;Lee Y.-F;Lin S.-Y;Lin C.-C;Lee J.-H;Bai Y.-Y;Liao B.-C; Liao B.-C; Bai Y.-Y; Lee J.-H; Lin C.-C; Lin S.-Y; Lee Y.-F; Ho C.-C; Shih J.-Y; Chang Y.-C; Yu C.-J; Chih-Hsin CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:26:28Z	Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non?�Small-cell Lung Cancer Patients	Wu T.-H; Hsiue E.H.-C; Lee J.-H; Lin C.-C; Liao W.-Y; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG; Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Liao W.-Y;Lin C.-C;Lee J.-H;Hsiue E.H.-C;Wu T.-H
臺大學術典藏	2020-05-26T09:26:26Z	Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion	Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Liu Y.-N;Wu S.-G; Wu S.-G; Liu Y.-N; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:20Z	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations	Lin Y.-T;Chen J.-S;Liao W.-Y;Ho C.-C;Hsu C.-L;Yang C.-Y;Chen K.-Y;Lee J.-H;Lin Z.-Z;Shih J.-Y;Chih-Hsin Yang;Yu C.-J.; Lin Y.-T; Chen J.-S; Liao W.-Y; Ho C.-C; Hsu C.-L; Yang C.-Y; Chen K.-Y; Lee J.-H; Lin Z.-Z; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:19Z	Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non?�small-cell lung cancer patients	Yao Z.-H;Liao W.-Y;Ho C.-C;Chen K.-Y;Shih J.-Y;Chen J.-S;Lin Z.-Z;Lin C.-C;Chih-Hsin Yang;Yu C.-J.; Yao Z.-H; Liao W.-Y; Ho C.-C; Chen K.-Y; Shih J.-Y; Chen J.-S; Lin Z.-Z; Lin C.-C; CHIH-HSIN YANG; Yu C.-J.

Showing items 1636-1660 of 2308 (93 Page(s) Totally)
<< < 61 62 63 64 65 66 67 68 69 70 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :2856708
	Visitors : 53587906 Online Users : 788 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library